Replies to post #205621 on Amarin Corp Plc (AMRN)

[raistthemage]

JL - I appreciate the line of thinking that a post label change secondary offering would be at a higher price but I think it was smarter to do it prior.

They would be PROFITABLE following sNDA there would be NO URGENCY to raise money and they could borrow if they had to.

It would be negotiation from strength instead of weakness.

JT diluting down here tells the market he doesn't believe in the stock and is worried about the FDA, why should anyone believe in the stock at higher prices if the CEO doesn't. Why shouldn't the market worry about the FDA if the CEO is worrying about the FDA?

Yes I know JT said at his conference call he isn't worried about the FDA, and we know JT well enough to know that he is conservative to the point of cowardice and wouldn't say that without assurances... but the market in general does not know that.

[Whalatane]

Bfost ...I think you made a very important pt when you stated

"We need to overwhelm the insurers to change tiers before 2020 "

I believe Eli Lily used a similar approach launching Trulicity ...act fast and act early re getting lower tiers ...followed by massive marketing campaign .
Kiwi